These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24677636)

  • 21. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
    Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
    PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
    Falkowski S; Woillard JB; Postil D; Tubiana-Mathieu N; Terrebonne E; Pariente A; Smith D; Guimbaud R; Thalamas C; Rouguieg-Malki K; Marquet P; Picard N
    BMC Cancer; 2017 Dec; 17(1):901. PubMed ID: 29282011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.
    Siemes C; Eijgelsheim M; Dieleman JP; van Schaik RH; Uitterlinden AG; van Duijn CM; Hofman A; Coebergh JW; Stricker BH; Visser LE
    Neth J Med; 2009 Apr; 67(4):134-41. PubMed ID: 19581657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
    Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey AB; Harper PA
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3098-107. PubMed ID: 18990750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry.
    Jiang X; Castelao JE; Vandenberg D; Carracedo A; Redondo CM; Conti DV; Paredes Cotoré JP; Potter JD; Newcomb PA; Passarelli MN; Jenkins MA; Hopper JL; Gallinger S; Le Marchand L; Martínez ME; Ahnen DJ; Baron JA; Lindor NM; Haile RW; Gago-Dominguez M
    PLoS One; 2013; 8(4):e60464. PubMed ID: 23560096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
    Cross JT; Poole EM; Ulrich CM
    Pharmacogenomics J; 2008 Aug; 8(4):237-47. PubMed ID: 18195728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid.
    van Oijen MG; Huybers S; Peters WH; Drenth JP; Laheij RJ; Verheugt FW; Jansen JB
    Br J Clin Pharmacol; 2005 Dec; 60(6):623-8. PubMed ID: 16305586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
    Barry EL; Poole EM; Baron JA; Makar KW; Mott LA; Sandler RS; Ahnen DJ; Bresalier RS; McKeown-Eyssen GE; Ulrich CM
    Cancer Causes Control; 2013 Jan; 24(1):47-54. PubMed ID: 23081681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk.
    Wang X; Su YR; Petersen PS; Bien S; Schmit SL; Drew DA; Albanes D; Berndt SI; Brenner H; Campbell PT; Casey G; Chang-Claude J; Gallinger SJ; Gruber SB; Haile RW; Harrison TA; Hoffmeister M; Jacobs EJ; Jenkins MA; Joshi AD; Li L; Lin Y; Lindor NM; Marchand LL; Martin V; Milne R; Maclnnis R; Moreno V; Nan H; Newcomb PA; Potter JD; Rennert G; Rennert H; Slattery ML; Thibodeau SN; Weinstein SJ; Woods MO; Chan AT; White E; Hsu L; Peters U
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1800-1808. PubMed ID: 32651213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.
    Chia VM; Newcomb PA; Bigler J; Morimoto LM; Thibodeau SN; Potter JD
    Cancer Res; 2006 Jul; 66(13):6877-83. PubMed ID: 16818666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
    Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk.
    Hu DG; Mackenzie PI; McKinnon RA; Meech R
    Drug Metab Rev; 2016; 48(1):47-69. PubMed ID: 26828111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.
    Wang X; Chan AT; Slattery ML; Chang-Claude J; Potter JD; Gallinger S; Caan B; Lampe JW; Newcomb PA; Zubair N; Hsu L; Schoen RE; Hoffmeister M; Brenner H; Le Marchand L; Peters U; White E
    Cancer Res; 2018 Aug; 78(16):4790-4799. PubMed ID: 29921691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.
    Coghill AE; Newcomb PA; Campbell PT; Burnett-Hartman AN; Adams SV; Poole EM; Potter JD; Ulrich CM
    Gut; 2011 Apr; 60(4):491-8. PubMed ID: 21051449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
    Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.
    Mackenzie PI; Miners JO; McKinnon RA
    Clin Chem Lab Med; 2000 Sep; 38(9):889-92. PubMed ID: 11097345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer.
    Vogel U; Christensen J; Dybdahl M; Friis S; Hansen RD; Wallin H; Nexø BA; Raaschou-Nielsen O; Andersen PS; Overvad K; Tjønneland A
    Mutat Res; 2007 Nov; 624(1-2):88-100. PubMed ID: 17544013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
    Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
    Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
    Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
    Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Review on gene polymorphisms of UDP-glucuronosyltransferases and genetic susceptibility of cancer].
    Wang Y; Zheng Y
    Wei Sheng Yan Jiu; 2008 Sep; 37(5):629-32. PubMed ID: 19069670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.